Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 2,602 | 2,903 | 2,996 | 3,154 | 3,408 | 3,520 | 3,826 | 4,618 | 4,730 | 4,999 | | 4,999 |
% Growth | NA | 11.6% | 3.2% | 5.3% | 8.0% | 3.3% | 8.7% | 20.7% | 2.4% | 5.7% | | |
| | | | | | | | | | | | |
Cost of Revenue | (1,490) | (1,707) | (1,772) | (1,913) | (2,047) | (2,130) | (2,347) | (2,916) | (3,038) | (3,035) | | (3,035) |
Gross Profit | 1,112 | 1,196 | 1,224 | 1,241 | 1,361 | 1,390 | 1,479 | 1,702 | 1,693 | 1,963 | | 1,963 |
% Revenue | 42.7% | 41.2% | 40.9% | 39.4% | 39.9% | 39.5% | 38.7% | 36.9% | 35.8% | 39.3% | | 39.3% |
| | | | | | | | | | | | |
Research and Development | (170) | (188) | (198) | (201) | (214) | (213) | (222) | (256) | (266) | (276) | | (276) |
Selling and Marketing | (427) | (467) | (478) | (490) | (533) | (534) | (564) | (681) | (676) | (699) | | (699) |
General and Admin | (158) | (161) | (164) | (174) | (183) | (203) | (221) | (258) | (276) | (299) | | (299) |
Other Inc / (Exp) | 29 | 16 | 30 | 41 | 26 | 38 | 79 | (26) | 70 | 21 | | 21 |
Total Operating Exp | (726) | (800) | (810) | (825) | (905) | (912) | (927) | (1,220) | (1,148) | (1,253) | | (1,253) |
| | | | | | | | | | | | |
Operating Income | 386 | 396 | 415 | 417 | 456 | 478 | 551 | 482 | 545 | 711 | | 711 |
% Revenue | 14.8% | 13.6% | 13.8% | 13.2% | 13.4% | 13.6% | 14.4% | 10.4% | 11.5% | 14.2% | | 14.2% |
| | | | | | | | | | | | |
Interest Expense | (35) | (38) | (39) | (28) | (47) | (55) | (35) | (51) | (80) | (65) | | (65) |
Pre-tax Income | 351 | 358 | 375 | 389 | 410 | 424 | 516 | 431 | 465 | 646 | | 646 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (99) | (97) | (100) | (109) | (112) | (109) | (131) | (140) | (120) | (164) | | (164) |
Net Income to Company | 252 | 261 | 276 | 280 | 298 | 315 | 385 | 291 | 345 | 482 | | 482 |
% Margin | 9.7% | 9.0% | 9.2% | 8.9% | 8.7% | 8.9% | 10.1% | 6.3% | 7.3% | 9.6% | | 9.6% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (6) | (8) | (5) | (4) | (7) | (8) | (10) | (11) | (4) | (4) | | (4) |
Net Income to Stockholders | 247 | 252 | 270 | 275 | 291 | 307 | 375 | 280 | 340 | 478 | | 478 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 247 | 252 | 270 | 275 | 291 | 307 | 375 | 280 | 340 | 478 | | 478 |
% Margin | 9.5% | 8.7% | 9.0% | 8.7% | 8.5% | 8.7% | 9.8% | 6.1% | 7.2% | 9.6% | | 9.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 1.90 | 1.94 | 2.08 | 2.12 | 2.16 | 2.27 | 2.74 | 2.00 | 2.44 | 3.42 | | 3.42 |
Diluted EPS (Continuing Ops) | 1.90 | 1.94 | 2.06 | 2.08 | 2.12 | 2.22 | 2.70 | 2.00 | 2.44 | 3.42 | | 3.42 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 129.81 | 129.81 | 129.81 | 129.81 | 134.80 | 135.43 | 136.63 | 139.77 | 139.77 | 139.77 | | 139.77 |
WA Diluted Shares Out. | 129.81 | 129.81 | 132.12 | 134.17 | 139.16 | 139.78 | 138.86 | 139.77 | 139.77 | 139.77 | | 139.77 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 351 | 358 | 375 | 389 | 410 | 424 | 516 | 431 | 465 | 646 | | 646 |
Addback: Net Interest Expense | 35 | 38 | 39 | 28 | 47 | 55 | 35 | 51 | 80 | 65 | | 65 |
Addback: Other Non Operating Expenses, Total | (0) | (6) | 8 | 7 | 0 | 6 | (9) | 123 | (11) | (4) | | (4) |
Addback: Depreciation & Amortization | 171 | 199 | 197 | 195 | 229 | 253 | 252 | 263 | 259 | 262 | | 262 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 22 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | (4) | (4) | 0 | (0) | (13) | (36) | (37) | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | (12) | (12) | (14) | (3) | | (3) |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | (21) | 3 | 12 | 16 | 6 | | 6 |
Adjusted EBITDA | 557 | 610 | 615 | 620 | 702 | 703 | 749 | 831 | 795 | 971 | | 971 |
% Margin | 21.4% | 21.0% | 20.5% | 19.7% | 20.6% | 20.0% | 19.6% | 18.0% | 16.8% | 19.4% | | 19.4% |
| | | | | | | | | | | | |
Adjusted EBIT | 386 | 411 | 418 | 424 | 473 | 450 | 496 | 568 | 536 | 709 | | 709 |
% Margin | 14.8% | 14.2% | 14.0% | 13.5% | 13.9% | 12.8% | 13.0% | 12.3% | 11.3% | 14.2% | | 14.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 252 | 261 | 276 | 280 | 298 | 315 | 385 | 291 | 345 | 482 | | 482 |
Addback: Unusual Items | 0 | 21 | (4) | 0 | 16 | (34) | (46) | (37) | 2 | 3 | | 3 |
Less: Tax Benefit of Unusual Items (26%) | 0 | (5) | 1 | 0 | (4) | 9 | 12 | 10 | (0) | (1) | | (1) |
Adjusted Net Income | 252 | 276 | 272 | 280 | 310 | 290 | 351 | 263 | 346 | 484 | | 484 |
% Margin | 9.7% | 9.5% | 9.1% | 8.9% | 9.1% | 8.2% | 9.2% | 5.7% | 7.3% | 9.7% | | 9.7% |